Revenue cycle · Autonomous medical coding AI
CodaMetrix
CodaMetrix is an autonomous medical coding platform that drafts codes from clinical documentation and routes exceptions to human coders. It is mid-cycle coding AI, not a patient billing portal.
Strong fit
- Health systems that want autonomous coding on professional and facility charts with human review on exceptions
- CDI and coding leaders comparing AI coding lift rather than only adding offshore coder seats
- Buyers that need specialty-aware coding automation with measurable auto-code rates
Weak fit
- Small practices that only need patient billing portals
- Groups that refuse any AI touch on coded claims
- Buyers shopping only for prior auth portals with no coding scope
Bottom line
CodaMetrix earns a Recommend on our revenue-cycle integrity board for health systems buying autonomous medical coding. The Boston company, led by President and CEO Hamid Tabatabaie, turns clinical documentation into draft codes with exception queues for human coders. Third-party estimates put revenue in a roughly $5-26M band with under 200 employees after sizable venture rounds, inside the prefer-to-mid band and under the hard cap. Implementation is a coding-ops and EHR/CDI integration project. Pricing is enterprise SaaS. Score sits with SmarterDx on AI coding depth and above thinner patient-pay tools when autonomous coding is the buy.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
CodaMetrix is a Boston autonomous medical coding company led by President and CEO Hamid Tabatabaie. Health systems use the platform to draft professional and facility codes from clinical documentation, then route exceptions to human coders instead of staffing every chart by hand.
It is mid-cycle coding AI, not a patient billing portal and not a prior auth bot. Compare Fathom when deep-learning coding automation is the shortlist frame, SmarterDx when CDI/diagnosis capture after the note is the pain, and Nym when professional-fee autonomous coding is the narrower buy.
Score reflects strong coding-automation outcomes with ordinary enterprise price opacity.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| SmarterDx | 7.6 | 7.2 |
| CodaMetrix | 7.6 | 7.3 |
| Fathom | 7.5 | 7.2 |
| Inbox Health | 7.4 | 7.1 |
| Collectly | 7.4 | 7.2 |
| MDaudit | 7.4 | 7.1 |
| Enter Health | 7.3 | 7.0 |
| Candid Health | 7.2 | 6.9 |
| Aptarro | 7.0 | 6.8 |
| PatientPay | 7.0 | 7.0 |
| Mentaya | 6.9 | 7.0 |
| MD Clarity | 6.9 | 6.7 |
| Nym | 6.6 | 6.4 |
| Rivia Health | 6.5 | 6.4 |
Pricing
| Item | Detail |
|---|---|
| Model | Enterprise SaaS for autonomous medical coding; quote-based health-system contracts. |
| What usually drives cost | Chart volume, specialty mix, auto-code target, and integration scope. |
| What to ask in diligence | Annual platform fee at your coded encounter volume, including model training and coder change management. |
| Published pricing | No public list price. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get CodaMetrix to function | |
| Coding leadership named | Exception queues need owners. |
| EHR and documentation feeds scoped | No notes means no codes. |
| Baseline auto-code and denial metrics | You cannot prove lift without a baseline. |
| BAA and security review complete | Coding AI stalls in procurement. |
| Coder change-management plan | Staff resist silent automation. |
| What will maximize your value | |
| Pilot one specialty first | Enterprise day-one multiplies noise. |
| Measure auto-code rate at 90 days | Prove coding lift. |
| Retire overlapping coding vendors | Duplicate queues confuse teams. |
| Deal-breakers | |
| Only need patient billing portals | |
| No documentation sharing allowed | |
| No coding owners available | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Security and data mapping | 4-8 weeks |
| 2 | Specialty pilot | 6-12 weeks |
| 3 | Scale coding automation | 4-8 weeks |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.